SOPH
SOPHiA GENETICS SA
8.30$
+1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.1% | -12.6% | +0.5% | -1.9% | -12.6% | -5.5% | +21.1% | -8.0% | -0.3% | -3.7% | +26.3% | |
| – | -3.3% | -15.5% | +0.5% | -6.8% | -15.2% | -9.4% | +30.0% | -11.6% | -4.3% | -3.3% | +43.3% | |
| – | -7.2% | -15.8% | +1.6% | -9.1% | -16.2% | -14.6% | +38.4% | -13.9% | -13.9% | -7.0% | +64.6% | |
| – | -7.2% | -15.8% | +1.6% | -9.1% | -16.2% | -14.6% | +38.4% | -13.9% | -13.9% | -7.0% | +64.6% | |
| – | +55.5% | -28.4% | -8.9% | -1.6% | -11.0% | +23.1% | -11.1% | -11.0% | +95.4% | -13.4% | -1.4% | |
| – | +24.8% | -7.2% | +8.8% | -1.0% | -9.4% | -13.9% | +23.1% | +7.4% | -4.9% | +11.6% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +259.6% | +12.5% | – | – | +274.9% | – | |
| – | -22.7% | +44.6% | +4.3% | +10.7% | -31.9% | +45.2% | +12.5% | +2.8% | -24.1% | – | – | |
| – | +15.4% | -12.2% | +24.2% | +7.5% | -8.2% | +3.9% | +65.2% | +1.8% | +12.8% | -4.0% | +3.5% | |
| – | +23.4% | -15.2% | -5.2% | +7.9% | -13.1% | +8.0% | +19.1% | +7.1% | +36.8% | -7.8% | +9.6% | |
| – | +0.7% | -7.7% | -5.0% | -3.6% | -11.6% | +4.5% | +8.6% | +5.0% | +3.5% | +0.5% | +0.3% | |
| – | -62.6% | +176.8% | -14.8% | +10.3% | -67.1% | +138.4% | +67.9% | -21.7% | -12.2% | +138.3% | -6.0% | |
| – | – | – | – | -1.4% | +0.6% | +0.6% | +256.4% | +0.2% | +0.3% | +0.2% | +0.3% | |
| – | -4.4% | -12.7% | -8.2% | -6.5% | -15.0% | -11.3% | -10.4% | -20.9% | -22.3% | -3.1% | +81.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | +0.4% | +0.9% | +0.7% | -0.7% | +1.4% | +0.7% | +0.7% | +0.7% | +4.2% | +3.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.